Interleukin-1β can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells

Cytokine

Volumn 29, Issue 3, 2005, Pages 125-134

  Park, Jong In ^a   Strock, Christopher J ^a   Ball, Douglas W ^a,b   Nelkin, Barry D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Differentiation; Interleukin 1 ; Leukemia inhibitory factor; MEK ERK; STAT3

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CALCITONIN; INTERLEUKIN 1BETA; JANUS KINASE; LEUKEMIA INHIBITORY FACTOR; NEUTRALIZING ANTIBODY; STAT PROTEIN; STAT3 PROTEIN; DNA BINDING PROTEIN; GLYCOPROTEIN GP 130; IL6ST PROTEIN, HUMAN; INTERLEUKIN 1; INTERLEUKIN 6; JAK3 PROTEIN, HUMAN; JANUS KINASE 3; LEUKOCYTE ANTIGEN; LIF PROTEIN, HUMAN; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 2; PROTEIN; PROTEIN TYROSINE KINASE; STAT3 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL CYCLE ARREST; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THYROID CARCINOMA; CELL DIFFERENTIATION; GENETICS; MEDULLARY CARCINOMA; METABOLISM; PHYSIOLOGY; THYROID TUMOR;

ANTIGENS, CD; CARCINOMA, MEDULLARY; CELL DIFFERENTIATION; CYTOKINE RECEPTOR GP130; DNA-BINDING PROTEINS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; JANUS KINASE 3; LEUKEMIA INHIBITORY FACTOR; MAP KINASE KINASE KINASE 1; MAP KINASE KINASE KINASE 2; MEMBRANE GLYCOPROTEINS; PROTEIN-TYROSINE KINASES; PROTEINS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; THYROID NEOPLASMS; TRANS-ACTIVATORS;

EID: 11144277904     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2004.10.005     Document Type: Article

References (59)

1. C.A. Dinarello Biologic basis for interleukin-1 in disease Blood 87 1996 2095 2147
2. C.A. Dinarello The IL-1 family and inflammatory diseases Clin Exp Rheumatol 20 2002 S1 S13
3. R.N. Apte, and E. Voronov Interleukin-1 - a major pleiotropic cytokine in tumor-host interactions Semin Cancer Biol 12 2002 277 290
4. J.M. Dayer The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis Rheumatology (Oxford) 42 2003 ii3 ii10
5. B. Mosley, S.K. Dower, S. Gillis, and D. Cosman Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1 alpha and 1 beta Proc Natl Acad Sci U S A 84 1987 4572 4576
6. J.P. Priestle, H.P. Schar, and M.G. Grutter The three-dimensional structure of interleukin-1 beta Biochem Soc Trans 16 1988 949 953
7. B.J. Graves, M.H. Hatada, W.A. Hendrickson, J.K. Miller, V.S. Madison, and Y. Satow Structure of interleukin 1 alpha at 2.7 - A resolution Biochemistry 29 1990 2679 2684
8. P.E. Auron The interleukin 1 receptor: ligand interactions and signal transduction Cytokine Growth Factor Rev 9 1998 221 237
9. B. Mosley, D.L. Urdal, K.S. Prickett, A. Larsen, D. Cosman, and P.J. Conlon The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor J Biol Chem 262 1987 2941 2944
10. D.T. Brody, and S.K. Durum Membrane IL-1: IL-1 alpha precursor binds to the plasma membrane via a lectin-like interaction J Immunol 143 1989 1183 1187
11. J.A. Maier, M. Statuto, and G. Ragnotti Endogenous interleukin 1 alpha must be transported to the nucleus to exert its activity in human endothelial cells Mol Cell Biol 14 1994 1845 1851
12. A.R. Gwosdow, N.A. O'Connell, and A.B. Abou-Samra Interleukin-1 increases protein kinase A activity by a cAMP-independent mechanism in AtT-20 cells Am J Physiol 266 1994 E79 E84
13. A. Huwiler, J. Brunner, R. Hummel, M. Vervoordeldonk, S. Stabel, and H. van den Bosch Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase Proc Natl Acad Sci U S A 93 1996 6959 6963
14. C. Schneider, N. Delorme, H. El Btaouri, W. Hornebeck, B. Haye, and L. Martiny Interleukin 1 beta (IL-1 beta) action in porcine thyroid cells involves the ceramide signalling pathway Cytokine 13 2001 174 178
15. A.J. Whitmarsh, S.H. Yang, M.S. Su, A.D. Sharrocks, and R.J. Davis Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors Mol Cell Biol 17 1997 2360 2371
16. W.A. Wilmer, L.C. Tan, J.A. Dickerson, M. Danne, and B.H. Rovin Interleukin-1beta induction of mitogen-activated protein kinases in human mesangial cells. Role of oxidation J Biol Chem 272 1997 10877 10881
17. J. Huang, X. Gao, S. Li, and Z. Cao Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein Proc Natl Acad Sci U S A 94 1997 12829 12832
18. K. Burns, F. Martinon, C. Esslinger, H. Pahl, P. Schneider, and J.L. Bodmer MyD88, an adapter protein involved in interleukin-1 signaling J Biol Chem 273 1998 12203 12209
19. S.B.A. Marmiroli, I. Faenza, A. Sirri, A. Ognibene, V. Cenni, and J. Tsukada Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I FEBS Lett 438 1998 49 54
20. A. Bavelloni, S. Santi, A. Sirri, M. Riccio, I. Faenza, and N. Zini Phosphatidylinositol 3-kinase translocation to the nucleus is induced by interleukin 1 and prevented by mutation of interleukin 1 receptor in human osteosarcoma Saos-2 cells J Cell Sci 112 1999 631 640
21. D.C. Ng, C.S. Long, and M.A. Bogoyevitch A role for the extracellular signal-regulated kinase and p38 mitogen-activated protein kinases in interleukin-1 beta-stimulated delayed signal transducer and activator of transcription 3 activation, atrial natriuretic factor expression, and cardiac myocyte morphology J Biol Chem 276 2001 29490 29498
22. J. Tsukada, W.R. Waterman, Y. Koyama, A.C. Webb, and P.E. Auron A novel STAT-like factor mediates lipopolysaccharide, interleukin 1 (IL-1), and IL-6 signaling and recognizes a gamma interferon activation site-like element in the IL1B gene Mol Cell Biol 16 1996 2183 2194
23. H.H. Lemmink, L. Tuyt, G. Knol, E. Krikke, and E. Vellenga Identification of LIL-STAT in monocytic leukemia cells and monocytes after stimulation with interleukin-6 or interferon γ Blood 98 2001 3849 3852
24. J. Bromberg, and J.E.J. Darnell The role of STATs in transcriptional control and their impact on cellular function Oncogene 19 2000 2468 2473
25. M. Merola, B. Blanchard, and M.G. Tovey The kappa B enhancer of the human interleukin-6 promoter is necessary and sufficient to confer an IL-1 beta and TNF-alpha response in transfected human cell lines: requirement for members of the C/EBP family for activity J Interferon Cytokine Res 16 1996 783 798
26. C.J. Auernhammer, and S. Melmed Leukemia-inhibitory factor-neuroimmune modulator of endocrine function Endocr Rev 21 2000 313 345
27. D. Knight Leukaemia inhibitory factor (LIF): a cytokine of emerging importance in chronic airway inflammation Pulm Pharmacol Ther 14 2001 169 176
28. T. Burdon, A. Smith, and P. Savatier Signalling, cell cycle and pluripotency in embryonic stem cells Trends Cell Biol 12 2002 432 438
29. A. Arici, O. Engin, E. Attar, and D.L. Olive Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium J Clin Endocrinol Metab 80 1995 1908 1915
30. C.D. Carlson, and R.P. Hart Activation of acidic sphingomyelinase and protein kinase C zeta is required for IL-1 induction of LIF mRNA in a Schwann cell line Glia 18 1996 49 58
31. C.J. Auernhammer, V. Chesnokova, and S. Melmed Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary- adrenal axis Endocrinology 139 1998 2201 2208
32. R.R. Gonzalez, B.R. Rueda, M.P. Ramos, R.D. Littell, S. Glasser, and P.C. Leavis Leptin induced increase in leukemia inhibitory factor and its receptor by human endometrium is partially mediated by interleukin 1 receptor signaling Endocrinology 145 2004 3850 3857
33. K. Nagamoto-Combs, S.A. Vaccariello, and R.E. Zigmond The levels of leukemia inhibitory factor mRNA in a Schwann cell line are regulated by multiple second messenger pathways J Neurochem 72 1999 1871 1881
34. J.I. Park, C.J. Strock, D.W. Ball, and B.D. Nelkin The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway Mol Cell Biol 23 2003 543 554
35. T. Nakagawa, M. Mabry, A. de Bustros, J.N. Ihle, B.D. Nelkin, and S.B. Baylin Introduction of v-H-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells Proc Natl Acad Sci U S A 84 1987 5923 5927
36. E.B. Carson, M. McMahon, S.B. Baylin, and B.D. Nelkin Ret gene silencing is associated with Raf-1 induced medullary thyroid carcinoma cell differentiation Cancer Res 55 1995 2048 2052
37. E.B. Carson-Walter, D.P. Smith, B.A. Ponder, S.B. Baylin, and B.D. Nelkin Post-transcriptional silencing of RET occurs, but is not required, during raf-1 mediated differentiation of medullary thyroid carcinoma cells Oncogene 17 1998 367 376
38. J.F. Bromberg, M.H. Wrzeszczynska, G. Devgan, Y. Zhao, R.G. Pestell, and C. Albanese Stat3 as an oncogene Cell 98 1999 295 303
39. H. Kotanides, M. Moczygemba, M.F. White, and N.C. Reich Characterization of the interleukin-4 nuclear activated factor/STAT and its activation independent of the insulin receptor substrate proteins J Biol Chem 270 1995 19481 19486
40. A. Arman, and P.E. Auron Interleukin 1 (IL-1) induces the activation of Stat3 Adv Exp Med Biol 534 2003 297 307
41. Y. Yoshida, A. Kumar, Y. Koyama, H. Peng, A. Arman, and J.A. Boch Interleukin 1 activates STAT3/nuclear factor-kappaB cross-talk via a unique TRAF6- and p65-dependent mechanism J Biol Chem 279 2004 1768 1776
42. K.W. Wood, H. Qi, G. D'Arcangelo, R.C. Armstrong, T.M. Roberts, and S. Halegoua The cytoplasmic raf oncogene induces a neuronal phenotype in PC12 cells: a potential role for cellular raf kinases in neuronal growth factor signal transduction Proc Natl Acad Sci U S A 90 1993 5016 5020
43. R.K. Ravi, E. Weber, M. McMahon, J.R. Williams, S. Baylin, and A. Mal Activated Raf-1 causes growth arrest in human small cell lung cancer cells J Clin Invest 101 1998 153 159
44. R.K. Ravi, A. Thiagalingam, E. Weber, M. McMahon, B.D. Nelkin, and M. Mabry Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small cell lung cancer cells Am J Respir Cell Mol Biol 20 1999 543 549
45. R.K. Ravi, M. McMahon, Z. Yangang, J.R. Williams, L.E. Dillehay, and B.D. Nelkin Raf-1-induced cell cycle arrest in LNCaP human prostate cancer cells J Cell Biochem 72 1999 458 469
46. C.P. Fanton, M. McMahon, and R.O. Pieper Dual growth arrest pathways in astrocytes and astrocytic tumors in response to Raf-1 activation J Biol Chem 276 2001 18871 18877
47. D. Boraschi, L. Nencioni, L. Villa, S. Censini, P. Bossu, and P. Ghiara In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human interleukin 1 beta J Exp Med 168 1988 675 686
48. C.S. McCune, and D.M. Marquis Interleukin 1 as an adjuvant for active specific immunotherapy in a murine tumor model Cancer Res 50 1990 1212 1215
49. V.K. Sondak, M.K. Tuck, S. Shu, H. Yoshizawa, and A.E. Chang Enhancing effect of interleukin 1 alpha administration on antitumor effector T-cell development Arch Surg 126 1991 1503 1508
50. T.J. Woodlock, D.M. Sahasrabudhe, D.M. Marquis, D. Greene, K.J. Pandya, and C.S. McCune Active specific immunotherapy for metastatic colorectal carcinoma: phase I study of an allogeneic cell vaccine plus low-dose interleukin-1 alpha J Immunother 22 1999 251 259
51. D.T. Harris, G.R. Matyas, L.G. Gomella, E. Talor, M.D. Winship, and L.E. Spitler Immunologic approaches to the treatment of prostate cancer Semin Oncol 26 1999 439 447
52. F.T. Stevenson, J. Turck, R.M. Locksley, and D.H. Lovett The N-terminal propiece of interleukin 1 alpha is a transforming nuclear oncoprotein Proc Natl Acad Sci U S A 94 1997 508 513
53. L. Vanhamme, G.M. Marshall, A.C. Schuh, M.L. Breitman, and P.K. Vogt Tumor necrosis factor alpha and interleukin 1 alpha induce anchorage independence in v-jun transgenic murine cells Cancer Res 53 1993 615 621
54. E. Voronov, D.S. Shouval, Y. Krelin, E. Cagnano, D. Benharroch, and Y. Iwakura IL-1 is required for tumor invasiveness and angiogenesis Proc Natl Acad Sci U S A 100 2003 2645 2650
55. D.M. Beaupre, M. Talpaz, F.C. Marini 3rd, R.J. Cristiano, J.A. Roth, and Z. Estrov Autocrine interleukin-1beta production in leukemia: evidence for the involvement of mutated RAS Cancer Res 59 1999 2971 2980
56. K. Bendtzen, K. Buschard, M. Diamant, T. Horn, and M. Svenson Possible role of IL-1, TNF-alpha, and IL-6 in insulin-dependent diabetes mellitus and autoimmune thyroid disease. Thyroid Cell Group Lymphokine Res 8 1989 335 340
57. Z.Q. Ning, J. Li, and R.J. Arceci Signal transducer and activator of transcription 3 activation is required for Asp(816) mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells Blood 97 2001 3559 3567
58. T.C. He, S. Zhou, L.T. da Costa, J. Yu, K.W. Kinzler, and B. Vogelstein A simplified system for generating recombinant adenoviruses Proc Natl Acad Sci U S A 95 1998 2509 2514
59. L.L. Vindelov, I.J. Christensen, and N.I. Nissen A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis Cytometry 3 1983 323 327